TABLE 5.
Comparison of change in coagulation function indexes between BYHW and control group after 3 months of treatment.
| BYHW (n = 34) | Control (n = 33) | p value | |
|---|---|---|---|
| PT (s) | |||
| Before treatment | 12.18 ± 1.34 | 11.92 ± 1.55 | 0.473 |
| After treatment | 12.83 ± 2.39 | 12.00 ± 1.76 | 0.112 |
| APTT (s) | |||
| Before treatment | 31.14 ± 4.14 | 30.99 ± 5.38 | 0.898 |
| After treatment | 34.30 ± 7.23* | 32.30 ± 8.03 | 0.287 |
| FIB (g/L) | |||
| Before treatment | 3.44 ± 0.75 | 3.43 ± 1.00 | 0.95 |
| After treatment | 2.83 ± 0.48** | 3.08 ± 0.59* | 0.054 |
| TT (s) | |||
| Before treatment | 14.79 ± 2.37 | 14.87 ± 2.91 | 0.907 |
| After treatment | 16.28 ± 2.13** | 15.07 ± 2.65 | 0.043 |
PT, prothrombin time; APTT, activation time of partial thromboplastin; FIB, fibrinogen; TT, thrombin time; compared with the same group before treatment, *p < 0.05, **p < 0.01.